These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16125299)

  • 1. IL-18 E42A mutant is resistant to the inhibitory effects of HPV-16 E6 and E7 oncogenes on the IL-18-mediated immune response.
    Lee KA; Cho KJ; Kim SH; Shim JH; Lim JS; Cho DH; Song MS; Dinarello CA; Yoon DY
    Cancer Lett; 2005 Nov; 229(2):261-70. PubMed ID: 16125299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange.
    Subbaramaiah K; Dannenberg AJ
    Cancer Res; 2007 Apr; 67(8):3976-85. PubMed ID: 17440114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an adenoviral vaccine against E6 and E7 oncoproteins to prevent growth of human papillomavirus-positive cancer.
    Lee DW; Anderson ME; Wu S; Lee JH
    Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1316-23. PubMed ID: 19075129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis.
    Divya CS; Pillai MR
    Mol Carcinog; 2006 May; 45(5):320-32. PubMed ID: 16526022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
    Welters MJ; Kenter GG; Piersma SJ; Vloon AP; Löwik MJ; Berends-van der Meer DM; Drijfhout JW; Valentijn AR; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; Melief CJ; van der Burg SH
    Clin Cancer Res; 2008 Jan; 14(1):178-87. PubMed ID: 18172269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both E6 and E7 oncoproteins of human papillomavirus 16 inhibit IL-18-induced IFN-gamma production in human peripheral blood mononuclear and NK cells.
    Lee SJ; Cho YS; Cho MC; Shim JH; Lee KA; Ko KK; Choe YK; Park SN; Hoshino T; Kim S; Dinarello CA; Yoon DY
    J Immunol; 2001 Jul; 167(1):497-504. PubMed ID: 11418688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
    Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
    J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity.
    Kenter GG; Welters MJ; Valentijn AR; Lowik MJ; Berends-van der Meer DM; Vloon AP; Drijfhout JW; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; van der Burg SH; Melief CJ
    Clin Cancer Res; 2008 Jan; 14(1):169-77. PubMed ID: 18172268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between cytokines and HPV-16, HPV-16 E6, E7, and high-risk HPV viral load in the uterine cervix.
    Song SH; Lee JK; Seok OS; Saw HS
    Gynecol Oncol; 2007 Mar; 104(3):732-8. PubMed ID: 17188341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
    Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
    Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
    Rampias T; Sasaki C; Weinberger P; Psyrri A
    J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
    Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of apoptosis in human laryngeal cancer cells by E6 and E7 oncoproteins of human papillomavirus 16.
    Liu HC; Chen GG; Vlantis AC; Tse GM; Chan AT; van Hasselt CA
    J Cell Biochem; 2008 Mar; 103(4):1125-43. PubMed ID: 17668439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pro-angiogenic factors stimulated by human papillomavirus type 16 E6 and E7 protein in C33A and human fibroblasts.
    Xi L; Wang S; Wang C; Xu Q; Li P; Tian X; Wu P; Wang W; Deng D; Zhou J; Ma D
    Oncol Rep; 2009 Jan; 21(1):25-31. PubMed ID: 19082439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
    Seo SH; Jin HT; Park SH; Youn JI; Sung YC
    Vaccine; 2009 Sep; 27(42):5906-12. PubMed ID: 19651174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha- and betapapillomavirus E6/E7 genes differentially modulate pro-inflammatory gene expression.
    De Andrea M; Mondini M; Azzimonti B; Dell'Oste V; Germano S; Gaudino G; Musso T; Landolfo S; Gariglio M
    Virus Res; 2007 Mar; 124(1-2):220-5. PubMed ID: 17079045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High levels of p105 (NFKB1) and p100 (NFKB2) proteins in HPV16-transformed keratinocytes: role of E6 and E7 oncoproteins.
    Havard L; Rahmouni S; Boniver J; Delvenne P
    Virology; 2005 Jan; 331(2):357-66. PubMed ID: 15629778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells.
    Rincon-Orozco B; Halec G; Rosenberger S; Muschik D; Nindl I; Bachmann A; Ritter TM; Dondog B; Ly R; Bosch FX; Zawatzky R; Rösl F
    Cancer Res; 2009 Nov; 69(22):8718-25. PubMed ID: 19887612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissimilar immunogenicities of human papillomavirus E7 and adenovirus E1A proteins influence primary tumor development.
    Routes JM; Ryan S; Li H; Steinke J; Cook JL
    Virology; 2000 Nov; 277(1):48-57. PubMed ID: 11062035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.